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Executive Summary
Introduction of the Problem
The use of intraoperative evoked potential (EP) neuromonitoring has increased from
31,762 cases in 2008 to 125,835 cases in 2014 (Laratta et al., 2018). This increase is
predominantly attributed to the overall efficacy of EP monitoring and early identification of
neurological morbidity. Surgeons utilize EP monitoring in a variety of surgical cases to assess
the effect of anesthesia and surgery on central and peripheral nervous system electrical
conductance (Laratta et al., 2018). This alerts the surgeon, anesthesia provider, and
neuromonitoring technician of any changes that could potentially result in permanent
neurological injury. The anesthesia staff at a tertiary care facility in central Illinois noted an
increase in cases that utilized EP monitoring and expressed the need for a guideline that
highlighted best practice for the anesthetic management of neuromonitoring cases. In addition,
the anesthesia staff expressed particular interest in the effects of dexmedetomidine
administration on EPs. Due to these important circumstances, a guideline was created to focus on
best practice recommendations that supported the use of intraoperative neuromonitoring.
Literature Review
Total Intravenous Anesthesia
Total intravenous anesthesia (TIVA) is the use of intravenous agents for induction and
maintenance of anesthesia. The most frequently used TIVA medications include propofol,
remifentanil, alfentanil, sufentanil, ketamine, midazolam, lidocaine, and dexmedetomidine
(Anderson & Bagshaw, 2019). TIVA has become increasingly more popular in recent years
because of the pharmacokinetic and pharmacodynamic properties of intravenous anesthetics and
the availability of short-acting synthetic opioids (Anderson & Bagshaw, 2019). Overall, the

research indicates the use of TIVA yields a more balanced anesthetic with greater hemodynamic
stability which results in a more predictable and reliable general anesthetic.
Evoked Potentials
Spinal surgery places the patient at high risk of spinal cord injury due to distraction,
ischemia, or compression of the nerves (Acharya et al., 2017). As a result, EP monitoring is used
to assess the neural integrity of sensory and motor pathways during surgeries near the spinal
cord. The monitoring of EPs is designed to prevent postoperative sensory and motor deficits in
surgeries including, but not limited to, herniated or ruptured disks, spinal stenosis,
spondylolisthesis, vertebral fractures, or degenerative disk disease. The two main monitoring
techniques for EPs are somatosensory evoked potentials (SSEPs) and motor evoked potentials
(MEPs).
Anesthesia and Evoked Potentials
Evoked potentials, including SSEPs and MEPs, can provide potential benefit in surgical
procedures involving manipulation of the spinal cord. These procedures require patients to be
placed under general anesthesia using a TIVA technique, as volatile anesthetic agents and
neuromuscular blockers negatively affect EP readings. Volatile anesthetics are potent
suppressants of EPs, particularly SSEPs. Despite their suppressant effects, studies have shown
when combined with intravenous medications, low doses of inhalational agents such as 0.5 MAC
(minimum alveolar concentration) have been successfully used during surgical cases without
compromising the quality of EP signals (Soghomonyan et al., 2014). Conversely, neuromuscular
blockers have been proven to significantly suppress MEPs and their use during EP monitoring of
surgical cases is not recommended (Sachdev et al., 2020). Collectively, medications should be
administered in accordance with general dosing parameters and titrated based on individualized

patient needs. Dexmedetomidine has been widely studied as an adjunct to TIVA and overall
results have indicated that there is no statistically relevant change in EP amplitude or latency at
therapeutic dosages (Li et al., 2016). Ultimately, the goal is to administer a drug regimen with
the least adverse effect possible on EP monitoring and patient hemodynamics, which is typically
accomplished by utilizing a multimodal anesthetic approach.
Project Methods
Purpose and Goals
The purpose of this project was to highlight current anesthetic best practice
recommendations and create an updated guideline for EP monitoring surgical cases. The main
goals of this project were to increase provider acceptance and buy-in of the updated TIVA
guideline, and to increase knowledge regarding appropriate medications for TIVA for EP
monitoring cases. This included recommended medication combinations, common medication
dosing, and drug effects on neuromonitoring.
Project Setting
This project was implemented in the main conference room at a tertiary care facility in
central Illinois. The project design was a non-experimental single-group design that consisted of
a convenience sample of certified registered nurse anesthetists (CRNAs) who were available for
participation at the time of project implementation.
IRB Information
The Institutional Review Board (IRB) at Southern Illinois University Edwardsville
reviewed and approved this project on June 28, 2021.
Evaluation
Tools and Measures

A guideline was created for the use of TIVA for EP monitoring surgical cases at the host
facility. This guideline was presented on September 24th, 2021, to all available staff on a
voluntary basis. Staff members that attended the project presentation were asked to answer a
thirteen-question survey to determine current knowledge and knowledge gained from the project.
Survey questions targeted understanding of EP monitoring, TIVA pharmacology, and current
anesthetic best practice recommendations for EP monitoring. Participants completed the survey
in Qualtrics, a web-based software that allows users to create surveys and generate reports.
Results were recorded and analyzed, and the data was incorporated into the final project.
Results
Demographic data showed that all participants in attendance were CRNAs. Participants
had a wide variety of experience levels, ranging from 1 year to over 10 years. Although
physician anesthesiologists were invited to the presentation there were no Medical Doctors of
Anesthesia (MDAs) in attendance.
Questions 3-11 were formatted using a Likert style scale with 1 representing “not at all”
and 10 representing “very much.” These questions assessed current knowledge and knowledge
gained regarding TIVA for EP cases, as well as the utility of the guideline in the operating room
(OR). Mean scores ranged from 7.5/10 to 10/10, indicating an overall positive response to the
survey questions and project itself.
Participants reported a relatively high level of baseline knowledge regarding TIVA for
EP monitoring (mean score of 7.5). However, this was the lowest mean score calculated,
indicating a potential need for further education on the subject. Participants reported increased
knowledge of TIVA pharmacology and ability to administer current best practice TIVA
protocols (mean score of 9), signifying confidence in the knowledge gained from the

presentation. Participants also agreed that the guideline represented current best practice
standards for anesthesia management of EP monitoring cases (mean score of 9.75), indicating a
high confidence level in the data presented. When the participants were asked about new
knowledge gained from the presentation a mean score of 8.75 was calculated, indicating that
there was some information that participants were previously unaware of. Additionally, results
indicated that providers were likely to incorporate this information into everyday practice (mean
score of 9.25), that it was appropriate for the OR setting (mean score of 9.75), and that the
guideline was user friendly (mean score of 10). These results indicate that that the guideline
could be understood and used by all providers that it was intended for.
The survey concluded with a series of open-ended questions that addressed the
effectiveness of the presentation and information provided. Participants reported that the
medication dosing guideline for EP monitoring was the most important part of the presentation.
This finding highlighted the efficacy of the updated guideline since a laminated copy could be
added to every OR for easy access. One participant stated that caution should be used with
dexmedetomidine since some of the surgeons prefer a higher dose propofol infusion instead. This
statement shows that for a project of this nature to be completely successful surgeon participation
and buy-in is essential, and surgeons need to be involved in future projects.
Limitations
The most significant limitation to this project was the sample size, with only four
providers being present during the initial presentation. This was mainly attributed to scheduling
difficulties and the inability for working providers to attend, as this presentation took place
during normal working hours. Future projects may benefit from presenting on a late-start day in
the OR where more providers would be available for a morning meeting. Lack of MDA and

surgeon presence was also a significant limitation, as their buy-in is essential to the success of
this project.
Impact on Practice
The results of the project revealed a strong desire to adopt the updated evidence-based
guideline into everyday practice. The adoption of this guideline has the potential to positively
affect patient safety and improve outcomes. This guideline gives providers the tools to provide
optimal anesthetic conditions for EP monitoring while also promoting rapid emergence from
anesthesia.
Conclusion
Proper dosing and administration of anesthetic agents during TIVA for EP monitoring
surgical cases is imperative to ensuring positive patient outcomes. Despite performing many
neuromonitoring cases per year, the host facility’s current TIVA guideline required updating
with the current best practice standards. The goals of this project were to update the current
TIVA guideline and educate the anesthesia staff regarding pertinent pharmacology and
anesthetic considerations for EP cases. A post-implementation survey assessed the participants’
current knowledge regarding TIVA for EP cases, knowledge gained, utility of the guideline, and
the probability of incorporating the guideline into daily practice. Overall results were positive
and demonstrated that presentation and guideline were effective tools that could aid in the
facility’s ability to administer optimal anesthesia for EP surgical cases. Adoption and
incorporation of this guideline in clinical practice has the potential to both improve patient
outcomes and increase provider confidence in administering anesthetic agents for these
important procedures.
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